Sign inJoin waitlistJoin the waitlist

Ross Okimoto

Associate Professor · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

University of California (San Francisco) School of Medicine
2012–2014
Internal Medicine
Tufts Medical Center
2009–2012
Creighton University School of Medicine
2005–2009

Research

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
New England Journal of Medicine · 2004 · 9,364 citations
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
Proceedings of the National Academy of Sciences of the United States of America · 2005 · 790 citations
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials
Journal of Clinical Oncology · 2005 · 523 citations

Trever Bivona
14 papers
RP
Rovingaile Ponce
10 papers · 1 as a resident
DH
Daniel Haber
9 papers
DS
Dennis Sgroi
5 papers
Collin Blakely
3 papers
Eunice Kwak
3 papers
HL
Henry Lynch
3 papers
SA
Siraj Ali
3 papers
Thomas Lynch
3 papers
Victor Olivas
3 papers
Andrew Horvai
2 papers
Anne Barmettler
2 papers

Grants

The Role of IL-6/STAT3 Signaling in CIC-DUX4 Fusion Sarcoma Metastasis and Immunosuppression
National Cancer Institute · R01
PI · $1.2M · Beckman Research Institute/City of Hope
2025–2030
Therapeutic Degradation of Capicua (CIC) Fused Oncoproteins in Undifferentiated Sarcomas
National Cancer Institute · R37
Contact PI · $2.7M · University of California, San Francisco
2021–2028
Therapeutic Rescue of the Transcriptional Repressor Capicua to Inhibit Lung Cancer Metastasis
National Cancer Institute · K08
Contact PI · $886.9K · University of California, San Francisco
2018–2023